a pink-haired woman blows a pink bubble
dhh-b a pink-haired woman blows a pink bubble

Ergoloid Mesylate 1 mg Nootropic for Mood and Mental Clarity ($1 per capsule best price)

$35.00$120.00

Clear

Ergoloid Mesylate is considered one of the world’s most useful nootropics as it improves age-related declines in mood, memory, and behavior.  This Nootropic is widely used to improve mental capacity and clarity of thinking and acts as an anti-depressant to decrease stress and anxiety.

Ergoloid mesylates have been shown to activate both D1and D2 dopamine receptors as well as decrease brain levels of MAO. The improvement in the dopamine system provides associated cognitive benefits and can also aid in treating depression and anxiety. Ergoloid mesylates have also been studied in hearing loss, sleep issues, migraines, and nerve damage.

Ergoloid mesylates have an FDA approved indication for treating elderly patients with symptoms of dementia. They are synthetically produced from a mixture of alkaloids derived from ergot, a fungus that grows on rye. Ergoloid mesylates block the alpha-adrenoreceptors which produce vasodilation and increase blood and oxygen supply to the brain.

  • Nootropic: improves memory and clarity of thinking
  • Works as an anti-depressant and treating anxiety
  • Improves mood by activating dopamine receptors

 

More Information.

We Also Recommend for You

a woman leans against a yellow all, wearing high heels

Ultra Burn (MIC 25/25/25mg) + B-12 capsule the Oral Liposuction for Fat Burning ($3.50 per capsule best price)

$120.00$420.00 Select options
a woman leans against a yellow all, wearing high heels

LipoStat Plus MIC/25mg/50mg/50mg, B6 175mcg, B12 1mg 30ml Injectable for Fat Mobilization (Doses 60)-GET $20 OFF 2ND VIAL

$190.00$360.00 Select options
a woman leans against a yellow all, wearing high heels

LDN aka Low Dose Naltrexone 3 mg capsule Diet-Pill for Craving Control ($1.80 per capsule best price)

$48.00$216.00 Select options
elfish woman with battle weapons in a forest

Sermorelin/Glycine Oral 500mcg/250mg Troche ($4.39 per troche best price)

$95.00$395.00 Select options
a woman leans against a yellow all, wearing high heels

7-keto DHEA 100mg Sustained-Release capsule – The Keto Diet Pill ($1.58 per capsule best price)

$63.00$189.00 Select options
woman lying down

DHH-B 7.5 mg capsules Nature’s Valium® for Anti-Anxiety (Quantity 30)

$89.00 Add to cart
a young woman on rollerskates holds grapes

Methylcobalamin (Methyl B-12) Injectable for Weight Loss, Energy and Mood 10mg/ml 30 ml (Doses 120)

$175.00 Add to cart
a woman holds a trophy in front of a classic pickup truck

GOAL + L-Citrulline + L-Carnitine – Amino Blend 30ml Injectable used in Weight Loss Clinics (Doses 60)-GET $20 OFF 2ND VIAL

$190.00$360.00 Select options
a warrior ninja woman with a dragon and flames

Armour Thyroid T3/T4 60 mg Tablet ($1.55 per tablet best price)

$75.00$279.00 Select options
elfish woman with battle weapons in a forest

Sermorelin/Glycine 2000mcg/5mg/ml 7.5ml Injectable (75 doses)

$225.00 Add to cart

Product Details

CLINICAL RESEARCH

A double-blind, placebo-controlled trial was carried out in 97 elderly patients with age-related mental deterioration to assess the efficacy of ergoloid mesylates in improving their symptoms. Patients were allocated at random to receive either 4.5 mg ergoloid mesylates per day or a matching placebo tablet and were followed-up for 6 months after the start of treatment. Clinical examinations were performed by the doctor, using the EACG rating scale (a French version of the Sandoz Clinical Assessment Geriatric scale), and by the nurse, using the NOSIE scale, when patients entered the trial and repeated after 2, 4 and 6 months. Changes in the factors (symptom groups) covered by these scales were subjected to statistical analysis. After 6-months’ treatment, a statistically significant difference in favour of the ergoloid mesylates group was observed for cognitive deficits (p less than 0.05), anxiety and mood depression (p less than 0.01), unsociability (p less than 0.01), retardation (p less than 0.05) and irritability (p less than 0.001). Treatment was very well tolerated. It was also observed that there was a progressive increase in efficacy throughout the trial; this indicates that treatment with ergoloid mesylates in patients with mental deterioration should be long-term.